Thornberry Nancy
Director
Sale 10b5-1
- Shares
- 615
- Price
- $23.74
- Value
- $14,600
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•26 filings
DNLI
Denali Therapeutics Inc.
Net sales of $326.8K over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$326,810
0 buyers · 2 sellers
12-month purchases
$39,977,138
6 distinct insiders
12-month sales
$326,810
2 distinct insiders
Highlighted alerts
2
4 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get DNLI insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
DNLI overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
40
Raw transactions
Everything returned by the filing
6
Voluntary view
P/S trades after deterministic checks
34
Administrative noise
Stored, never alerted
5
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 1,654
- Price
- $22.29
- Footnotes
- 4
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.28 to $22.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Includes 142,845 Unvested RSU's Includes 1,790 shares acquired under the ESPP Purchase on June 1, 2026.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Thornberry Nancy
Director
Sale 10b5-1
- Shares
- 10,824
- Price
- $22.85
- Value
- $247,328
Schuth Alexander O.
COFO and Secretary
Sale 10b5-1
- Shares
- 2,768
- Price
- $23.44
- Value
- $64,882
BAKER BROS. ADVISORS LP
Director
PurchaseAlert
- Shares
- 2,095,191
- Price
- $17.49
- Value
- $36,644,891
BAKER BROS. ADVISORS LP
Director
PurchaseAlert
- Shares
- 190,523
- Price
- $17.49
- Value
- $3,332,247
Ho Carole
Chief Medical Officer
Sale 10b5-1
- Shares
- 806
- Price
- $14.64
- Value
- $11,800
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 02, 2026 | Thornberry Nancy Director | Sale | 615 | $23.74 | $14,600 | |
| Sep 02, 2026 | Thornberry Nancy Director | Sale | 10,824 | $22.85 | $247,328 | |
| Sep 01, 2026 | Schuth Alexander O. COFO and Secretary | Sale | 2,768 | $23.44 | $64,882 | |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP Director | Purchase | 2,095,191 | $17.49 | $36,644,891 | |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP Director | Purchase | 190,523 | $17.49 | $3,332,247 | |
| Aug 13, 2025 | Ho Carole Chief Medical Officer | Sale | 806 | $14.64 | $11,800 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.